Evidence map›Paper›PMID 30060759›Full record

ReviewVeterinary research2018

Vaccines as alternatives to antibiotics for food producing animals. Part 2: new approaches and potential solutions.

Karin Hoelzer, Lisa Bielke, Damer P Blake, Eric Cox, Simon M Cutting, Bert Devriendt, Elisabeth Erlacher-Vindel, Evy Goossens, Kemal Karaca, Stephane Lemiere and 6 more

Open access · goldAbstract readReview
In one paragraph

Review in Veterinary research, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed
7.4field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 84 citations in OpenAlex.

  1. Review
  2. Avian PathogenicVeterinary sciences · 2025
    Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Microorganisms · 2024
    Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Recombinant AttenuatedVaccines · 2023
    Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 8 institutions in 4 countries.

Karin HoelzerThe Pew Charitable Trusts, 901 E Street NW, Washington, DC, 20004, USA. khoelzer@pewtrusts.org.ORCID 0000-0003-2350-1062
Lisa BielkeOhio Agriculture and Research Development Center, Animal Sciences, Ohio State University, 202 Gerlaugh Hall, 1680 Madison Ave., Wooster, OH, 44691, USA.
Damer P BlakePathobiology and Population Sciences, Royal Veterinary College, University of London, Hawkshead Lane, North Mymms, Hertfordshire, AL9 7TA, UK.
Eric CoxDepartment of Virology, Parasitology and Immunology, Faculty of Veterinary Medicine, Ghent University, Salsiburylaan 133, 9820, Merelbeke, Belgium.
Simon M CuttingSchool of Biological Sciences, Royal Holloway University of London, Egham, Surrey, TW20 0EX, UK.
Bert DevriendtDepartment of Virology, Parasitology and Immunology, Faculty of Veterinary Medicine, Ghent University, Salsiburylaan 133, 9820, Merelbeke, Belgium.
Elisabeth Erlacher-VindelScience and New Technologies Department, World Organisation for Animal Health (OIE), 12 Rue de Prony, 75017, Paris, France.
Evy GoossensDepartment of Pathology, Bacteriology and Avian Diseases, Faculty of Veterinary Medicine, Ghent University, Salsiburylaan 133, 9820, Merelbeke, Belgium.
Kemal KaracaElanco Animal Health, 2500 Innovation Way, Greenfield, IN, USA.
Stephane LemiereMerial, 29 Avenue Tony Garnier, 69007, Lyon, France.
Martin MetznerRIPAC-LABOR GmbH, Am Mühlenberg 11, 14476, Potsdam, Germany.
Margot RaicekScience and New Technologies Department, World Organisation for Animal Health (OIE), 12 Rue de Prony, 75017, Paris, France.
Miquel Collell SuriñachMSD, 2 Giralda Farms, Madison, NJ, USA.
Nora M WongThe Pew Charitable Trusts, 901 E Street NW, Washington, DC, 20004, USA.
Cyril GayOffice of National Programs, Agricultural Research Service, USDA, Sunnyside Ave, 5601, Beltsville, MD, USA.
Filip Van ImmerseelDepartment of Pathology, Bacteriology and Avian Diseases, Faculty of Veterinary Medicine, Ghent University, Salsiburylaan 133, 9820, Merelbeke, Belgium.
Ghent University · BEOrganisation Mondiale de la Santé Animale · FRPew Charitable Trusts · USAgricultural Research Service · USElanco (United States) · USRoyal Holloway University of London · GBThe Ohio State University · USUniversity of London · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Vaccines and other alternative products are central to the future success of animal agriculture because they can help minimize the need for antibiotics by preventing and controlling infectious diseases in animal populations. To assess scientific advancements related to alternatives to antibiotics and provide actionable strategies to support their development, the United States Department of Agriculture, with support from the World Organisation for Animal Health, organized the second International Symposium on Alternatives to Antibiotics. It focused on six key areas: vaccines; microbial-derived products; non-nutritive phytochemicals; immune-related products; chemicals, enzymes, and innovative drugs; and regulatory pathways to enable the development and licensure of alternatives to antibiotics. This article, the second part in a two-part series, highlights new approaches and potential solutions for the development of vaccines as alternatives to antibiotics in food producing animals; opportunities, challenges and needs for the development of such vaccines are discussed in the first part of this series. As discussed in part 1 of this manuscript, many current vaccines fall short of ideal vaccines in one or more respects. Promising breakthroughs to overcome these limitations include new biotechnology techniques, new oral vaccine approaches, novel adjuvants, new delivery strategies based on bacterial spores, and live recombinant vectors; they also include new vaccination strategies in-ovo, and strategies that simultaneously protect against multiple pathogens. However, translating this research into commercial vaccines that effectively reduce the need for antibiotics will require close collaboration among stakeholders, for instance through public-private partnerships. Targeted research and development investments and concerted efforts by all affected are needed to realize the potential of vaccines to improve animal health, safeguard agricultural productivity, and reduce antibiotic consumption and resulting resistance risks.

Indexed as

Animal HusbandryAnimalsAnti-Bacterial AgentsLivestockUnited StatesVaccinationVaccinesAnti-Bacterial AgentsVaccines

Identifiers

PMID30060759
PMCPMC6066917
OpenAlexW2883600975

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.